Table 2 Clinical characteristics of pediatric COVID-19
From: Epidemiological and clinical features of pediatric COVID-19
Classification | Characteristic (No., %) |
|---|---|
Clinical diagnosis | 341 |
Asymptomatic | 20 (5.9%) |
With abnormal chest radiograph | 6 (30%) |
Mild/moderate | 318 (99.3%) |
Severe | 2 (0.6%) |
Critical | 1 (0.3%) |
Clinical symptoms | 136 |
Fever (37.3~40 °C) | 106 (77.9%) |
Cough | 44 (32.4%) |
Lacrimation | 6 (4.4%) |
Stuffy nose | 3 (2.2%) |
Sneezing | 1 (0.7%) |
Sore throat | 3 (2.2%) |
Dyspnea | 3 (2.2%) |
Nausea & vomiting | 4 (2.9%) |
Diarrhea | 6 (4.4%) |
Conjunctivitis | 1 (0.7%) |
Dizziness and headache and myalgia | 3 (2.2%) |
Fatigue | 3 (2.2%) |
Body discomfort | 3 (2.2%) |
Coexisting disorders | 136 |
Congenital heart | 2 (1.5%) |
Complications | 136 |
Heart failure | 1 (0.7%) |
Myocardial injury | 6 (4.4%) |
Liver injury | 3 (2.2%) |
Acute respiratory distress syndrome/shock/acute kidney injury | 1 (0.7%) |
Treatment | 62 |
Antiviral treatment | 33 (53.2%) |
TCM | 27 (43.5%) |
Antibiotic treatment | 17 (27.4%) |
Nutritional support therapy | 17 (27.4%) |
Symptomatic treatment | 17 (27.4%) |
Interferon therapy | 7 (11.3%) |
Immunoglobulin therapy | 4 (6.5%) |
Psychological intervention | 2 (3.2%) |
Not taking medicine | 1 (1.6%) |
Glucocorticoid therapy | 1 (1.6%) |
Mechanical ventilation | 1 (1.6%) |
Clinical outcome | |
Death | 0/341 |
Time from onset to cure (days) | 218 |
Median (range) | 16 (6–39) |
Quartile (Q1–Q3) | 13–21 |